AstraZeneca is working on a vaccine against Omicron

AstraZeneca is working on Omicron vaccine

AstraZeneca is working with Oxford University to produce a vaccine adapted to the Omicron coronavirus strain.

Reuters reports.

Pharmaceutical the company has joined other manufacturers in developing a vaccine that will be effective against the South African strain.

When it will be available to consumers has not yet been specified.

Add a Comment

Your email address will not be published. Required fields are marked *